Overview
Lissencephaly type 1 due to doublecortin (DCX) gene mutation, also known as X-linked lissencephaly or subcortical band heterotopia (SBH), is a rare brain malformation disorder caused by mutations in the DCX gene located on the X chromosome. The DCX gene encodes doublecortin, a protein essential for neuronal migration during embryonic brain development. When this gene is mutated, neurons fail to migrate properly to their correct positions in the cerebral cortex, resulting in a smooth brain surface (lissencephaly) or abnormal bands of misplaced neurons beneath the cortex (subcortical band heterotopia, also called "double cortex" syndrome). This condition predominantly affects the central nervous system. In hemizygous males, the presentation is typically more severe, with classical lissencephaly characterized by a smooth or nearly smooth brain surface, severe intellectual disability, intractable epilepsy (often infantile spasms), feeding difficulties, and significant motor impairment including spasticity. Affected males may also have microcephaly. In heterozygous females, the phenotype is generally milder due to random X-inactivation, often presenting as subcortical band heterotopia with variable degrees of intellectual disability and epilepsy. Some females may have normal intelligence with seizures as the primary manifestation. There is currently no cure or disease-modifying treatment for lissencephaly type 1 due to DCX mutations. Management is supportive and symptomatic, focusing primarily on seizure control with antiepileptic medications, physical and occupational therapy to optimize motor function, speech therapy, nutritional support (sometimes requiring gastrostomy tube placement), and management of respiratory complications. Genetic counseling is important for affected families given the X-linked inheritance pattern. Prognosis varies significantly between males and females, with severely affected males often having a shortened lifespan, while females with subcortical band heterotopia may have a more favorable outcome.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Lissencephaly type 1 due to doublecortin gene mutation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Lissencephaly type 1 due to doublecortin gene mutation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Lissencephaly type 1 due to doublecortin gene mutation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Lissencephaly type 1 due to doublecortin gene mutation.
Community
No community posts yet. Be the first to share your experience with Lissencephaly type 1 due to doublecortin gene mutation.
Start the conversation →Latest news about Lissencephaly type 1 due to doublecortin gene mutation
No recent news articles for Lissencephaly type 1 due to doublecortin gene mutation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Lissencephaly type 1 due to doublecortin gene mutation
What is Lissencephaly type 1 due to doublecortin gene mutation?
Lissencephaly type 1 due to doublecortin (DCX) gene mutation, also known as X-linked lissencephaly or subcortical band heterotopia (SBH), is a rare brain malformation disorder caused by mutations in the DCX gene located on the X chromosome. The DCX gene encodes doublecortin, a protein essential for neuronal migration during embryonic brain development. When this gene is mutated, neurons fail to migrate properly to their correct positions in the cerebral cortex, resulting in a smooth brain surface (lissencephaly) or abnormal bands of misplaced neurons beneath the cortex (subcortical band hetero
How is Lissencephaly type 1 due to doublecortin gene mutation inherited?
Lissencephaly type 1 due to doublecortin gene mutation follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Lissencephaly type 1 due to doublecortin gene mutation typically begin?
Typical onset of Lissencephaly type 1 due to doublecortin gene mutation is neonatal. Age of onset can vary across affected individuals.